Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia
- 15 July 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 260 (3), 345-347
- https://doi.org/10.1001/jama.260.3.345
Abstract
Research from JAMA — Risk Factors for Hypoglycemia Associated With Pentamidine Therapy for Pneumocystis PneumoniaThis publication has 9 references indexed in Scilit:
- Use of a Specific and Sensitive Assay to Determine Pentamidine Pharmacokinetics in Patients with AIDSThe Journal of Infectious Diseases, 1986
- Hypoglycemia in Hospitalized PatientsNew England Journal of Medicine, 1986
- Trimethoprim-Sulfamethoxazole or Pentamidine forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndromeClinical Pharmacology & Therapeutics, 1986
- Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitroDiabetologia, 1985
- Diabetogenic effect of pentamidineAmerican Journal Of Medicine, 1984
- Pentamidine, a new diabetogenic drug in laboratory rodentsDiabetologia, 1983
- Acute pancreatitis associated with pentamidine therapyArchives of Internal Medicine, 1981
- Pentamidine Isethionate in the Treatment of Pneumocystis carinii PneumoniaAnnals of Internal Medicine, 1970